Marksans Pharma

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue362.63418.04433.77452.56479.83
Expenses313.39375.76372.02386.35415.93
EBITDA49.2442.2861.7566.2163.90
EBIT40.6820.9250.6352.1651.16
Profit Before Tax60.3552.6076.4577.8379.20
Net Profit49.1228.1159.7161.2563.41
Financial Ratios
Operating Profit Margin13.58%10.11%14.24%14.63%13.32%
Net Profit Margin13.55%6.72%13.77%13.53%13.22%
Earning Per Share (Diluted)1.200.691.481.521.56
Dividends Per ShareNA0.25NANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI